Breakfast Brief: Shatavari personalized: Does one static dose fit every life stage?

Women’s hormonal physiology changes across the reproductive years, perimenopause, and menopause. Each life stage represents a distinct hormonal environment and unique phase of the female life cycle — yet botanical extracts are often studiedy through a static, one-dose-fits-all hormonal stage framework.

Could shatavari (Asparagus racemosus) dosing be optimized for women’s specific hormonal life stages?

Join this briefing with Diana Morgan, founder of Pink Catalyst Consulting, who brings broad perspective on bringing health and wellness products to market. She’ll to explore the rationale behind life-stage optimized dosing of adaptogenic shatavari, and how aspurus® dose-optimization studies can help formulators move beyond a one static dose towards more targeted, personalized, and clinically differentiated women’s health formulations.

Takeaways:

• Gain clinical insights from studies in female sexual wellness, perimenopause and postmenopause.
• Learn about Life stage optimized dose (reproductive age women - 300mg/ perimenopause- 500mg/ menopause- 250mg) Explore how this can support greater personalization.
• Understand how aspurus® full spectrum shatavari root extract mimics the shatavari root’s phytoprofile while retaining seven identified bioactives and 5% shatavarins.

Speaker:

• Diana Morgan, founder, Pink Catalyst Consulting

Click here to add to your badge registration.

**Registration for this session is subject to approval by the sponsoring company, which reserves the right to manage final attendance.